Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 2.51% is 97% below its 5-year average of 77.23%, near the low end of its 5-year range (2.51%–220.51%).
As of the fiscal period ended Tuesday, June 30, 2026. 47.14% below its 12-month average of 4.74%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.51%.
DEBT TO ASSETS RATIO
2.51%
DEBT TO ASSETS RATIO AVG TTM
4.74%
DEBT TO ASSETS RATIO AVG 3Y
4.86%
DEBT TO ASSETS RATIO AVG 5Y
77.23%
DEBT TO ASSETS RATIO AVG 10Y
83.92%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-47.14%
CURRENT VS 3Y AVG
-48.43%
CURRENT VS 5Y AVG
-96.75%
CURRENT VS 10Y AVG
-97.01%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 536 covered companies
CURRENT VS SECTOR MEDIAN
+2406.90%
vs the sector median at left
BioStem Technologies, Inc.
Market Cap
$44.50M
Debt to Assets Ratio
2.51%
TTM Avg
4.74%
3Y Avg
4.86%
5Y Avg
77.23%
Market Cap
$44.90M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$42.82M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$47.30M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$38.77M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$38.70M
Debt to Assets Ratio
0.58%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | $44.50M | 2.51% | 4.74% | 4.86% | 77.23% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.90M | 0.00% | N/A | N/A | N/A |
| DarioHealth Corp. (DRIO)vs › | $45.92M | 0.34% | N/A | N/A | N/A |
| Filana Therapeutics, Inc. (FLNA)vs › | $42.82M | 0.00% | N/A | N/A | N/A |
| Lite Strategy, Inc. (LITS)vs › | $47.30M | 0.00% | N/A | N/A | N/A |
| CVRx, Inc. (CVRX)vs › | $41.66M | 0.64% | N/A | N/A | N/A |
| Clene Inc. (CLNN)vs › | $49.58M | 0.97% | N/A | N/A | N/A |
| Incannex Healthcare Limited (IXHL)vs › | $38.77M | 0.00% | N/A | N/A | N/A |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.70M | 0.58% | N/A | N/A | N/A |
| Edesa Biotech, Inc. (EDSA)vs › | $38.53M | 0.00% | N/A | N/A | N/A |
Debt/Assets
2.5%
Debt/Equity
0.04
Current Ratio
0.98
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 2.51% |
| 2026-03-31 | 5.95% |
| 2025-12-31 | 6.64% |
| 2025-09-30 | 5.43% |
| 2025-06-30 | 3.19% |
| 2025-03-31 | 2.88% |
| 2024-12-31 | 3.13% |
| 2024-09-30 | 4.30% |
| 2024-06-30 | 5.04% |
| 2024-03-31 | 9.55% |
| 2023-12-31 | 32.44% |
| 2023-09-30 | 103.62% |
| 2023-06-30 | 175.81% |
| 2023-03-31 | 161.83% |
| 2022-12-31 | 146.81% |
| 2022-09-30 | 126.14% |
| 2022-06-30 | 111.00% |
| 2022-03-31 | 123.28% |
| 2021-12-31 | 183.12% |
| 2021-09-30 | 188.72% |
| 2021-06-30 | 220.51% |
| 2021-03-31 | 206.18% |
| 2020-12-31 | 210.81% |
| 2020-09-30 | 186.17% |
| 2020-06-30 | 181.04% |
| 2020-03-31 | 169.88% |
| 2019-12-31 | 162.15% |
| 2018-12-31 | 120.94% |
| 2018-09-30 | 61.74% |
| 2018-06-30 | 57.80% |
| 2018-03-31 | 34.25% |
| 2017-12-31 | 41.84% |
| 2017-09-30 | 34.21% |
| 2017-06-30 | 19.70% |
| 2017-03-31 | 18.12% |
| 2016-12-31 | 15.48% |
| 2016-09-30 | 28.87% |
| 2016-06-30 | 17.87% |
| 2016-03-31 | 20.05% |
| 2015-12-31 | 17.03% |
| 2015-09-30 | 1.88% |
| 2015-06-30 | 1.98% |
| 2015-03-31 | 2.02% |
| 2014-12-31 | 161.30% |
| 2014-09-30 | 28.42% |
| 2014-06-30 | 16.92% |
| 2014-03-31 | 23.80% |
| 2013-12-31 | 21.67% |
| 2013-09-30 | 18.53% |
| 2013-06-30 | 41.34% |
| 2013-03-31 | 31.98% |
